Edwards Lifesciences | EW - Interest Expense On Debt


Edwards Lifesciences reported $30M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Abbott USD 297M 2M Sep/2026
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.2M 15K Jun/2026
Baxter International USD 64M 14M Jun/2026
Becton, Dickinson and Co. USD 130M 2M Sep/2026
Boston Scientific USD 100M 4M Sep/2026
Cooper Companies USD 21.5M 600K Jun/2026
Dexcom USD 3.1M 100K Sep/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Globus Medical USD 5.53B 39.93M Sep/2026
ICU Medical USD 18.56M 24K Jun/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 12.3M 1.3M Sep/2026
Integra LifeSciences USD 22.96M 33K Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 186M 10M Jun/2026
Merit Medical Systems USD 7.33M 4.78M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Tandem Diabetes Care USD 1.16B 5.29M Sep/2026
Teleflex USD 21.21M 6.75M Sep/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026